Close Menu

NEW YORK – Dutch biotech startup Epify announced today that it has raised €500,000 ($547,000) in seed funding.

The firm will use the funding to develop a portfolio of biomarkers discovered by Maastricht University professor Manon van Engeland to detect colorectal cancer (CRC). Founded by Engeland, Epify anticipates offering the biomarkers for non-invasive diagnosis of CRC at the earliest stage possible to allow patients to benefit from therapeutic interventions while they are still healthy.  

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.